Objective Tumour heterogeneity represents a major obstacle to accurate diagnosis and
treatment in gastric adenocarcinoma (GA). Here, we report a systematic transcriptional atlas …

Gastric cancer (GC) is the second most common cause of cancer-related deaths. It is known
to be a heterogeneous disease with several molecular and histological subtypes. Here we …

Background Deregulated gene expression is a hallmark of cancer; however, most studies to
date have analyzed short-read RNA sequencing data with inherent limitations. Here, we …

Gastric cancer (GC) is a highly heterogeneous disease. To identify potential clinically
actionable therapeutic targets that may inform individualized treatment strategies, we …

Background Although recent advances in high-throughput technology have provided many
insights into gastric cancer (GC), few reliable biomarkers for diffuse-type GC have been …

Single-cell transcriptomic profiles analysis has proposed new insights for understanding the
behavior of human gastric cancer (GC). GC offers a unique model of intratumoral …

Gastric cancer (GC) remains the fifth most prevalent cancer worldwide and the third leading
cause of global cancer mortality. Comprehensive‐omic studies have unveiled a …

Background Deciphering intra‐and inter‐tumoural heterogeneity is essential for
understanding the biology of gastric cancer (GC) and its metastasis and identifying effective …

Intestinal-type gastric cancer is preceded by premalignant lesions, including chronic
atrophic gastritis and intestinal metaplasia. In this study, we constructed a single-cell atlas …

Gastric cancer, a leading cause of cancer-related deaths, is a heterogeneous disease. We
aim to establish clinically relevant molecular subtypes that would encompass this …